STRN3-NTRK1: A Novel NTRK1 Oncogenic Fusion in a Patient with Lung Adenocarcinoma

J Thorac Oncol. 2020 Feb;15(2):e23-e24. doi: 10.1016/j.jtho.2019.08.2508.

Authors

Rongguo Lu¹, Chuang Qi², Mingzhe Xiao², Shangli Cai², Mingfeng Zheng³

Affiliations

¹ Department of General Thoracic Surgery, Lung Transplantation Group, Wuxi People's Hospital, Nanjing Medical University, Wuxi, People's Republic of China.
² Medical Department, 3D Medicines Inc., Shanghai, People's Republic of China.
³ Department of General Thoracic Surgery, Lung Transplantation Group, Wuxi People's Hospital, Nanjing Medical University, Wuxi, People's Republic of China. Electronic address: [email protected].

PMID: 32127185
DOI: 10.1016/j.jtho.2019.08.2508

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma of Lung / genetics
Autoantigens
Calmodulin-Binding Proteins
Humans
Lung Neoplasms* / genetics
Oncogene Fusion
Oncogenes
Receptor Protein-Tyrosine Kinases
Receptor, trkA / genetics

Substances

Autoantigens
Calmodulin-Binding Proteins
STRN3 protein, human
Receptor Protein-Tyrosine Kinases
Receptor, trkA